MET Immunoassay Quality Control, Data Analysis, and Reporting
BRD ID: 3044
Tier: SOP
Source: DCTD
Number of times downloaded: 319
Description
This document describes procedures for establishing quality control parameters and analyzing and reporting mesenchymal epithelial transition factor (MET) levels obtained by enzyme-linked immunosorbent assay in lysates from frozen tumor biopsies and quality control methods for assay validation. It is a product of the National Cancer Institute's (NCI) Division of Cancer Treatment and Diagnosis (DCTD; https://dctd.cancer.gov/). Please check the DCTD website (https://dctd.cancer.gov/drug-discovery-development/assays) for the current SOP version.
Biospecimens
TissueNot specified
Diagnoses
NeoplasticNot specified
Topics
Platform-specific Methodology